The expression of the acetylated H3 and H4 reader BRD4 is enhanced in HCC [225, 226], and treatment with the BRD4 inhibitor JQ-1 reduced HCC cell growth and survival [227, 228]. The gene discussed is BRD4; the disease is hepatocellular carcinoma.